Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?
Expert Opinion on Therapeutic Targets | November 22, 2021 | Volume: 25 | Issue: 10 | Pages: 835-845
10.1080/14728222.2021.2010046